Budapest, Hungary

Berta Knoll


Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1981-1990

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Berta Knoll: A Pioneer in Pharmaceutical Innovations

Introduction

Berta Knoll is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, holding a total of seven patents. Her work focuses on developing innovative therapeutic compounds that exhibit unique properties.

Latest Patents

Among her latest patents, Berta has developed pharmaceutical compositions that include a compound known as 3-amino-4-ethylthio-quinoline. This compound and its pharmaceutically acceptable acid addition salts possess useful therapeutic properties. They exhibit a potent and highly selective anxiolytic and narcosis potentiating effect while being devoid of sedative and anti-convulsive effects. Additionally, her invention relates to a new and improved process for preparing this compound. Another significant patent involves quinoline thioethers, which are new compounds characterized by a general formula that includes various alkyl and alkenyl groups.

Career Highlights

Berta Knoll has worked with prominent companies in the pharmaceutical industry, including Egis Gyógyszergyár and Richter Gedeon Vegyészeti Gyár Rt. Her experience in these organizations has allowed her to contribute to the advancement of pharmaceutical sciences significantly.

Collaborations

Berta has collaborated with notable individuals in her field, including Jozsef Knoll and Lujza E. Petocz. These collaborations have enriched her research and development efforts, leading to innovative solutions in pharmaceuticals.

Conclusion

Berta Knoll's contributions to pharmaceutical innovations are commendable, showcasing her dedication to improving therapeutic options. Her patents reflect her expertise and commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…